CClinicalTrials.gg
CompletedNCT00292539Updated Apr 23, 2009

Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA Class

An observational study in Atrial Fibrillation, Bradycardia and Heart Block, sponsored by Guidant Corporation. Completed at 1 site in Germany. Per ClinicalTrials.gov, last updated 2009-04-23.

Sponsored by Guidant Corporation · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
600
Sex
All
01

Study summary

This registry is a data collection on patients who are implanted for more than 6 months with a pacemaker. Frequency and distribution of right ventricular pacing, NYHA class and left ventricular ejection fraction shall be documented.

02

Conditions studied

  • Atrial Fibrillation
  • Bradycardia
  • Heart Block
  • Sick Sinus Syndrome

Keywords

  • Pacemaker
  • NYHA class
  • Ejection fraction
  • Heart Failure
03

In context

Atrial Fibrillation

3,870 studies on the registry are indexed under Atrial Fibrillation; 924 are open to participants now.

This study's enrollment of 600 is above the median of 300 across 1,363 observational studies indexed under Atrial Fibrillation.

Browse Atrial Fibrillation studies →

Lead sponsor

Guidant Corporation is the lead sponsor of 17 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Implanted pacemaker for more than 6 months, VVI/DDD, written consent

Exclusion criteria

Exclusion Criteria:

  • Pacemaker implanted for less than 6 months, no right ventricular pacing possibility (AAI), no consent
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
600 participants

Interventions

  • DeviceAny pacemaker with right ventricular pacing option
06

Study locations

1 site
  • Kreiskrankenhaus
    Viechtach, 94234, Germany
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 23, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00292539
Lead sponsor
Guidant Corporation
First posted
Feb 16, 2006
Start date
Feb 2006
Completion
Sep 2006
Last update
Apr 23, 2009

Study contacts

Sven Treusch, PHD
study director · Guidant Corporation
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion